Jade Biosciences, Inc.
JBIO
$12.00
$0.383.27%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 3.06% | 55.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.36% | 18.79% | |||
| Operating Income | 1.36% | -18.79% | |||
| Income Before Tax | 21.66% | 15.81% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 21.66% | 15.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 21.66% | 15.81% | |||
| EBIT | 1.36% | -18.79% | |||
| EBITDA | 1.39% | -- | |||
| EPS Basic | 44.16% | 90.26% | |||
| Normalized Basic EPS | 30.32% | 86.24% | |||
| EPS Diluted | 44.16% | 90.26% | |||
| Normalized Diluted EPS | 30.32% | 86.24% | |||
| Average Basic Shares Outstanding | 39.23% | 728.10% | |||
| Average Diluted Shares Outstanding | 39.23% | 728.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||